Healthcare provider profile · identity verified

Alphonsus Ligouri Flannery, MD

Family Practice · CORINTH, MS · NPI 1104899129

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	737	100
Alprazolam	Alprazolam	554	75
Amlodipine Besylate	Amlodipine Besylate	435	75
Pantoprazole Sodium	Pantoprazole Sodium	432	79
Potassium Chloride	Potassium Chloride	382	68
Metoprolol Succinate	Metoprolol Succinate	363	59
Levothyroxine Sodium	Levothyroxine Sodium	329	45
Gabapentin	Gabapentin	320	48
Famotidine	Famotidine	307	54
Clopidogrel	Clopidogrel Bisulfate	283	44
Furosemide	Furosemide	270	49
Losartan Potassium	Losartan Potassium	233	38
Rosuvastatin Calcium	Rosuvastatin Calcium	218	47
Levofloxacin	Levofloxacin	214	125
Atorvastatin Calcium	Atorvastatin Calcium	211	39
Omeprazole	Omeprazole	199	42
Allopurinol	Allopurinol	187	25
Lisinopril	Lisinopril	187	32
Meloxicam	Meloxicam	186	30
Prednisone	Prednisone	178	86
Trazodone Hcl	Trazodone Hcl	143	29
Carvedilol	Carvedilol	141	21
Diazepam	Diazepam	141	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	138	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	135	18
Metformin Hcl	Metformin Hcl	131	21
Montelukast Sodium	Montelukast Sodium	116	18
Ezetimibe	Ezetimibe	115	18
Simvastatin	Simvastatin	111	19
Jardiance	Empagliflozin	109	17
Temazepam	Temazepam	105	16
Hydrochlorothiazide	Hydrochlorothiazide	103	22
Tamsulosin Hcl	Tamsulosin Hcl	103	24
Zolpidem Tartrate	Zolpidem Tartrate	93	11
Promethazine Hcl	Promethazine Hcl	87	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	21
Eliquis	Apixaban	86	15
Escitalopram Oxalate	Escitalopram Oxalate	85	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	83	35
Lorazepam	Lorazepam	83	18
Albuterol Sulfate Hfa	Albuterol Sulfate	80	16
Azithromycin	Azithromycin	79	60
Xarelto	Rivaroxaban	75	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	73	12
Ozempic	Semaglutide	72	suppressed
Sertraline Hcl	Sertraline Hcl	67	suppressed
Clonidine Hcl	Clonidine Hcl	66	11
Metoprolol Tartrate	Metoprolol Tartrate	66	suppressed
Ondansetron Odt	Ondansetron	66	21
Pregabalin	Pregabalin	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	63	25
Citalopram Hbr	Citalopram Hydrobromide	62	11
Mirtazapine	Mirtazapine	57	suppressed
Clonazepam	Clonazepam	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Bupropion Xl	Bupropion Hcl	53	suppressed
Topiramate	Topiramate	53	suppressed
Estradiol	Estradiol	49	suppressed
Mupirocin	Mupirocin	49	32
Tizanidine Hcl	Tizanidine Hcl	49	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Metformin Hcl Er	Metformin Hcl	48	suppressed
Spironolactone	Spironolactone	47	suppressed
Fluconazole	Fluconazole	46	22
Glimepiride	Glimepiride	46	suppressed
Nitroglycerin	Nitroglycerin	45	25
Amiodarone Hcl	Amiodarone Hcl	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Cefdinir	Cefdinir	40	28
Tramadol Hcl	Tramadol Hcl	40	suppressed
Vascepa	Icosapent Ethyl	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Nifedipine Er	Nifedipine	36	suppressed
Flecainide Acetate	Flecainide Acetate	35	suppressed
Sucralfate	Sucralfate	35	suppressed
Cephalexin	Cephalexin	34	15
Buspirone Hcl	Buspirone Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Ranolazine Er	Ranolazine	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Dexlansoprazole Dr	Dexlansoprazole	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Sotalol	Sotalol Hcl	26	suppressed
Brilinta	Ticagrelor	24	suppressed
Clotrimazole	Clotrimazole	23	17
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Bumetanide	Bumetanide	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Amoxicillin	Amoxicillin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Valsartan	Valsartan	20	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Colchicine	Colchicine	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Linzess	Linaclotide	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ubrelvy	Ubrogepant	15	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acitretin	Acitretin	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Digoxin	Digoxin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clonidine Hcl Er	Clonidine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error